sepsis
The molecular test is used to differentiate bacterial infections, viral infections, and noninfectious disease and to assess the risk that patients will develop severe illness.
CARB-X Grants Melio $3.5M for Neonatal Sepsis Test, Visby Wins Additional $3.9M
The Melio funding will support a diagnostic test using acoustic sample prep and melt curve detection.
T2 Biosystems to Outlicense Infectious Disease Testing Technology
The firm said its T2 Magnetic Resonance technology for testing whole-blood samples could be paired with fluorescence and other testing methods.
Pattern Bioscience Wins BARDA Contract Worth up to $40.9M
The contract's base award is $22.5 million, which Pattern said will support the late-stage development of its single-cell microbiology ID and AST system.
T2 Biosystems Preliminary Q3 Revenues up 33 Percent; Reaches Deal With Cardinal Health
The firm executed contracts for 11 T2Dx instruments in the quarter and saw its sepsis test panel revenue increase 42 percent.